Pancreatic cancer cells use the non-canonical KRAS-induced glutamine pathway to maintain redox homeostasis, supporting cell growth by increasing the nicotinamide adenine dinucleotide phosphate (NADPH/NADP +) ratio [74]. This evidence concerns the gene KRAS and pancreatic neoplasm.